1 – 10 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome
Brueffer, Christian LU
;
Gladchuk, Sergii
LU
;
Winter, Christof
LU
;
Vallon-Christersson, Johan
LU
;
Hegardt, Cecilia
LU
;
Häkkinen, Jari
LU
;
George, Anthony
LU
;
Chen, Yilun
LU
;
Ehinger, Anna
LU
and
Larsson, Christer
LU
, et al.
(2020)
Mark
-
The generalisability of randomised clinical trials : an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
de Boniface, Jana ; Ahlgren, Johan ; Andersson, Yvette ; Bergkvist, Leif ; Frisell, Jan ; Lundstedt, Dan ; Olofsson Bagge, Roger ; Rydén, Lisa LU
and
Sund, Malin
(2020)
In Breast Cancer Research and Treatment
Mark
-
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
Malmberg, Martin LU ; Larsson, Christer LU ; Vallon-Christersson, Johan LU
;
Ehinger, Anna
LU
;
Hegardt, Cecilia
LU
;
Killander, Fredrika
LU
;
Ryden, Lisa
LU
;
Saal, Lao
LU
;
Loman, Niklas
LU
and
Borg, Åke
LU
(2020)
San Antonio Breast Cancer Symposium, 2019
In Cancer research. Supplement
80(Issue 4 Supplement).
p.1-18
Mark
-
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
Staaf, Johan LU
;
Glodzik, Dominik
LU
;
Bosch Campos, Ana
LU
;
Vallon-Christersson, Johan
LU
;
Reuterswärd, Christel
LU
;
Häkkinen, Jari
LU
;
Degasperi, Andrea
;
Amarante, Tauanne Dias
;
Saal, Lao
LU
and
Hegardt, Cecilia
LU
, et al.
(2020)
UK Interdisciplinary Breast Cancer Symposium 2020
In Breast Cancer Research and Treatment
180.
p.531-532
Mark
-
Barriers and facilitators for individualized rehabilitation during breast cancer treatment- A focus group study exploring health care professionals' experiences
Olsson Möller, Ulrika LU ; Olsson, Ing-Marie ; Sjövall, Katarina LU ; Beck, Ingela LU ; Rydén, Lisa LU
and
Malmström, Marlene
LU
(2020)
In BMC Health Services Research
20.
Mark
-
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
Larsson, Anna Maria LU ; Bendahl, Pär Ola LU ; Aaltonen, Kristina LU ; Jansson, Sara LU ; Forsare, Carina LU ; Bergqvist, Mattias ; Jørgensen, Charlotte Levin Tykjær LU and Rydén, Lisa LU
(2020)
In Scientific Reports
10.
Mark
-
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
Jørgensen, Charlotte Levin Tykjær LU ; Forsare, Carina LU ; Bendahl, Pär Ola LU ; Falck, Anna Karin LU ; Fernö, Mårten LU ; Lövgren, Kristina LU ; Aaltonen, Kristina LU and Rydén, Lisa LU
(2020)
In Breast Cancer Research and Treatment
181(2).
p.369-381
Mark
-
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
Tutzauer, Julia LU
;
Sjöström, Martin
LU
;
Bendahl, Pär Ola
LU
;
Rydén, Lisa
LU
;
Fernö, Mårten
LU
;
Fredrik Leeb-Lundberg, L. M.
LU
and
Alkner, Sara
LU
(2020)
In PLoS ONE
15(4).
Mark
-
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells
Forsare, Carina LU ; Bendahl, Pär Ola LU ; Moberg, Eric LU ; Jørgensen, Charlotte Levin Tykjær LU ; Jansson, Sara LU ; Larsson, Anna Maria LU ; Aaltonen, Kristina LU and Rydén, Lisa LU
(2020)
In International Journal of Molecular Sciences
21(8).
Mark
-
Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden
Velickovic, Katarina LU ; Rahm Hallberg, Ingalill LU ; Axelsson, Ulrika LU
;
Borrebaeck, Carl A.K.
LU
;
Rydén, Lisa
LU
;
Johnsson, Per
LU
and
Månsson, Johanna
LU
(2020)
In Health and Quality of Life Outcomes
18(1).
Mark